Sen. Wiener has introduced a separate bill, SB 41, that could have a much bigger impact on the affordability of insulin and other drugs. It targets pharmacy benefit managers, or PBMs ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...